Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

15.78 -0.34 (-2.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,150,400
Open 16.12
Bid (Size) 15.78 (1)
Ask (Size) 15.86 (10)
Prev. Close 16.12
Today's Range 15.75 - 16.18
52wk Range 3.060 - 21.13
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
Amphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January. 
Via Investor's Business Daily

Performance

YTD
+246.81%
+246.81%
1 Month
-18.32%
-18.32%
3 Month
+18.11%
+18.11%
6 Month
+151.67%
+151.67%
1 Year
+400.95%
+400.95%

More News

Read More
Key Takeaways From ADMA Biologics Analyst Ratings
Via Benzinga
Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits
Via Investor's Business Daily
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
Via Benzinga
This Is What Whales Are Betting On ADMA Biologics
Via Benzinga
IBD 50's Top Stock, ADMA Biologics, Crashes After Auditor Unexpectedly Resigns
Via Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Exploring high growth characteristics of ADMA BIOLOGICS INC (NASDAQ:ADMA).
Via Chartmill
Looking for growth without the hefty price tag? Consider NASDAQ:ADMA.
Via Chartmill
In-Depth Examination Of 4 Analyst Recommendations For ADMA Biologics
Via Benzinga
ADMA Biologics Set to Join S&P SmallCap 600 Index
From ADMA Biologics, Inc.
Via GlobeNewswire
Assessing ADMA Biologics: Insights From 4 Financial Analysts
Via Benzinga
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
From ADMA Biologics, Inc.
Via GlobeNewswire
What's Going On With ADMA Biologics Stock Monday?
Via Benzinga
Topics Stocks
Exposures US Equities
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
Via Benzinga
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark
Via Investor's Business Daily
'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics
Via Benzinga
Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers
Via Investor's Business Daily
Biohaven Stock Earns Relative Strength Rating Upgrade
Via Investor's Business Daily
SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
Via Investor's Business Daily
Immunome Stock Sees RS Rating Jump To 91
Via Investor's Business Daily
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
From ADMA Biologics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.